Publisher： Bentham Science Publishers
E-ISSN： 1875-5933|3|3|227-229
ISSN： 1568-010X
Source： Current Drug Targets. Inflammation & Allergy, Vol.3, Iss.3, 2004-09, pp. : 227-229
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Anti-IgE monoclonal antibody E25 beneficial in allergic asthma
Inpharma, Vol. 1, Iss. 1220, 2000-01 ,pp. :
Novel anti-IgE monoclonal antibody promising against allergic diseases
Inpharma, Vol. 1, Iss. 1232, 2000-01 ,pp. :
Anti-IgE Therapy in Allergic Asthma
Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 5, 2005-10 ,pp. :
IgE, Allergic Diseases, and Omalizumab
Current Pharmaceutical Design, Vol. 12, Iss. 30, 2006-10 ,pp. :